Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hemoregulatory peptide 5b

Known as: L-Lysine, N2-(N-(N-(N-(5-oxo-L-prolyl)-L-alpha-glutamyl)-L-alpha-aspartyl)-L-cysteinyl)-, SP1 pentapeptide, pyroglutamyl-glutamyl-aspartyl-cysteinyl-lysine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The granulocyte-derived hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys = pEEDCK is known to keep hematopoietic cells quiescent… Expand
Is this relevant?
1998
1998
We have previously shown that the pentapeptide pGlu-Glu-Asp-Cys-Lys (pEEDCK), which is associated with mature leukocytes… Expand
Is this relevant?
1997
1997
The hemoregulatory peptide, pGlu-Glu-Asp-Cys-Lys (pEEDCK or HP5b), has been shown to reversibly inhibit the proliferation of bone… Expand
Is this relevant?
1995
1995
Insertion of foreign genes into cellular DNA requires (at least one round of) DNA replication. Since hemopoietic stem cells do… Expand
Is this relevant?
1994
1994
During the Third International Conference on Negative Control of Hematopoiesis (Paris, April 1993), a special session was devoted… Expand
Is this relevant?
1993
1993
Pre--CFU-S are characterized by their ability to generate spleen colony-forming cells (CFU-S) and by their ability to repopulate… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1991
1991
We have previously shown that the synthetic peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK monomer) inhibits the cytostatic drug-induced… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • table 1
Is this relevant?
Review
1991
Review
1991
Cytostatic drug-induced haematopoietic damage is a major problem in tumour chemotherapy, due to the intensive proliferation of… Expand
Is this relevant?
1990
1990
The hemoregulatory peptide (pGlu-Glu-Asp-Cys-Lys, pEEDCK) is a potent inhibitor of stem cell recruitment, which is a major source… Expand
Is this relevant?